Compare SMTI & LCNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SMTI | LCNB |
|---|---|---|
| Founded | 1982 | 1877 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 208.2M | 223.1M |
| IPO Year | 2008 | 1999 |
| Metric | SMTI | LCNB |
|---|---|---|
| Price | $21.83 | $17.30 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $34.00 | N/A |
| AVG Volume (30 Days) | ★ 48.6K | 18.5K |
| Earning Date | 05-12-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 5.43% |
| EPS Growth | N/A | ★ 68.04 |
| EPS | 0.05 | ★ 0.31 |
| Revenue | ★ $15,586,976.00 | $6,445,000.00 |
| Revenue This Year | $17.31 | $8.50 |
| Revenue Next Year | $12.48 | $3.66 |
| P/E Ratio | $435.00 | ★ $54.90 |
| Revenue Growth | ★ 32.47 | N/A |
| 52 Week Low | $16.05 | $14.11 |
| 52 Week High | $35.70 | $17.89 |
| Indicator | SMTI | LCNB |
|---|---|---|
| Relative Strength Index (RSI) | 50.76 | 58.33 |
| Support Level | $20.50 | $17.08 |
| Resistance Level | $24.17 | $17.48 |
| Average True Range (ATR) | 1.46 | 0.50 |
| MACD | -0.15 | 0.02 |
| Stochastic Oscillator | 42.99 | 92.26 |
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.
LCNB Corp operates within the financial sector in the United States. As the holding company of the National Bank, it conducts the business of providing commercial and personal banking services. Its suite of banking products includes commercial and industrial loans, consumer loans, safe deposit boxes, night depositories, cashier's checks, utility bill collections, and notary public service. Besides, it provides the avenue of United States Treasury notes, the United States agency notes, certificates of deposit, and equity securities.